Skip to main content
. Author manuscript; available in PMC: 2023 Jul 17.
Published in final edited form as: Vaccine. 2021 Feb 12;39(10):1485–1492. doi: 10.1016/j.vaccine.2021.02.004

Table 2.

Hepatitis B virus infection status among children born in 2006–2015 by survey site — Ukraine, 2017

Survey site Uninfected
(anti-HBc-negative)
Infected, infection cleared
(anti-HBc-positive and HBsAg-negative)
Chronic infection
(anti-HBc-positive and HBsAg-positive)*
No. Weighted
%
95% CI No. Weighted
%
95% CI No. Weighted
%
95% CI
Zakarpattya
(N=1,268)
1,212 94.8 91.3–96.9 50 4.5 2.6–7.9 6 0.7 0.3–1.4
Sumy
(N=1,380)
1,368 99.2 98.4–99.6 11 0.7 0.3–1.5 1 0.1 0.0–0.4
Odessa
(N=1,265)
1,251 99.0 97.8–99.6 14 1.0 0.4–2.2 0 0.0 0.0–0.3**
Kyiv City
(N=683)
676 98.9 97.7–99.5 6 1.0 0.4–2.1 1 0.1 0.0–0.8

Anti-HBc, antibodies against core antigen of hepatitis B virus; HBsAg, surface antigen of hepatitis B virus; CI, confidence interval; N, total number of children tested

*

The likelihood of encountering acute infections in a cross- sectional survey conducted in a low prevalence setting is very low [21], therefore, anti-HBc-positive and HBsAg-positive cases found in the survey are considered chronic HBV infections

**

Crude estimate of CI (due to zero value of prevalence)